Cystamine prevents ischemia-reperfusion injury by inhibiting polyamination of RhoA

Biochemical and Biophysical Research Communications

Volumn 365, Issue 3, 2008, Pages 509-514

  Shin, Dong Myung ^a   Kang, Jinmo ^a,b   Ha, Jongwon ^a   Kang, Heun Soo ^a   Park, Sang Chul ^a   Kim, In Gyu ^a   Kim, Sang Joon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Dankook University College of Medicine   (South Korea)

Author keywords

Cystamine; Ischemia reperfusion injury; Organ preservation solution; Rho associated kinase; Transglutaminase2

Indexed keywords

CASPASE; CYSTAMINE; F ACTIN; LACTATE DEHYDROGENASE; POLYAMINE; PRESERVATION SOLUTION; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; HEART MUSCLE CELL; HYPOXIA; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN INTERACTION; RAT; REOXYGENATION; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CELL LINE; COLD; CYSTAMINE; ENZYME INHIBITORS; GTP-BINDING PROTEINS; L-LACTATE DEHYDROGENASE; MYOCYTES, CARDIAC; ORGAN PRESERVATION SOLUTIONS; POLYAMINES; RATS; REPERFUSION INJURY; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; TRANSGLUTAMINASES;

RATTUS;

EID: 36549021047     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.007     Document Type: Article

References (29)

1. Solaini G., and Harris D.A. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem. J. 390 (2005) 377-394
2. Ferrari R., Ceconi C., Curello S., Alfieri O., and Visioli O. Myocardial damage during ischaemia and reperfusion. Eur. Heart J. 14 (1993) 25-30
3. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
4. Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., Matsuura Y., and Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271 (1996) 20246-20249
5. Yada T., Shimokawa H., Hiramatsu O., Kajita T., Shigeto F., Tanaka E., Shinozaki Y., Mori H., Kiyooka T., Katsura M., Ohkuma S., Goto M., Ogasawara Y., and Kajiya F. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo. J. Am. Coll. Cardiol. 45 (2005) 599-607
6. Shiotani S., Shimada M., Suehiro T., Soejima Y., Yosizumi T., Shimokawa H., and Maehara Y. Involvement of Rho-kinase in cold ischemia-reperfusion injury after liver transplantation in rats. Transplantation 78 (2004) 375-382
7. Mizunuma K., Ohdan H., Tashiro H., Fudaba Y., Ito H., and Asahara T. Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor. Transplantation 75 (2003) 579-586
8. Glyn M.C., Lawrenson J.G., and Ward B.J. A Rho-associated kinase mitigates reperfusion-induced change in the shape of cardiac capillary endothelial cells in situ. Cardiovasc. Res. 57 (2003) 195-206
9. Lorand L., and Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4 (2003) 140-156
10. Masuda M., Betancourt L., Matsuzawa T., Kashimoto T., Takao T., Shimonishi Y., and Horiguchi Y. Activation of Rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin. EMBO J. 19 (2000) 521-530
11. Singh U.S., Kunar M.T., Kao Y.L., and Baker K.M. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J. 20 (2001) 223-2413
12. Johnson T.S., Abo-Zenah H., Skill J.N., Bex S., Wild G., Brown C.B., Griffin M., and El Nahas A.M. Tissue transglutaminase: a mediator and predictor of chronic allograft nephropathy?. Transplantation 77 (2004) 1667-1675
13. Jeon J.H., Lee H.J., Jang G.Y., Kim C.W., Shin D.M., Cho S.Y., Yeo E.J., Park S.C., and Kim I.G. Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine. Exp. Mol. Med. 36 (2004) 576-581
14. Lesort M., Lee M., Tucholski J., and Johnson G.V. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J. Biol. Chem. 278 (2003) 3825-3830
15. Hicks M., Hing A., Gao L., Ryan J., and Macdonald P.S. Organ preservation. Methods Mol. Biol. 333 (2006) 331-374
16. Shin D.M., Jeon J.H., Kim C.W., Cho S.Y., Kwon J.C., Lee H.J., Choi K.H., Park S.C., and Kim I.G. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J. Biol. Chem. 279 (2004) 15032-15039
17. Jeon J.H., Choi K.H., Cho S.Y., Kim C.W., Shin D.M., Kwon J.C., Song K.Y., Park S.C., and Kim I.G. Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine. EMBO J. 22 (2003) 5273-5282
18. Muhlbacher F., Langer F., and Mittermayer C. Preservation solutions for transplantation. Transplant. Proc. 31 (1999) 2069-2070
19. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
20. Berruyer C., Martin F.M., Castellano R., Macone A., Malergue F., Garrido-Urbani S., Millet V., Imbert J., Dupre S., Pitari G., Naquet P., and Galland F. Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol. Cell. Biol. 24 (2004) 7214-7224
21. O'Brian C.A., and Chu F. Post-translational disulfide modifications in cell signaling--role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission. Free Radic. Res. 39 (2005) 471-480
22. Chu F., Chen L.H., and O'Brian C.A. Cellular protein kinase C isozyme regulation by exogenously delivered physiological disulfides-implications of oxidative protein kinase C regulation to cancer prevention. Carcinogenesis 25 (2004) 585-596
23. Singh U.S., Pan J., Kao Y.L., Joshi S., Young K.L., and Baker K.M. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Biol. Chem. 278 (2003) 391-399
24. Radeff J.M., Nagy Z., and Stern P.H. Rho and Rho Kinase Are Involved in Parathyroid Hormone-Stimulated Protein Kinase C α Translocation and IL-6 Promoter Activity in Osteoblastic Cells. J. Bone Mineral Res. 19 (2004) 1882-1891
25. Matsumoto Y., Uwatoku T., Oi K., Abe K., Hattori T., Morishige K., Eto Y., Fukumoto Y., Nakamura K.-i., Shibata Y., Matsuda T., Takeshita A., and Shimokawa H. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 181-186
26. Hattori T., Shimokawa H., Higashi M., Hiroki J., Mukai Y., Kaibuchi K., and Takeshita A. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice. Cir. Res. 94 (2004) 46-52
27. Higashi M., Shimokawa H., Hattori T., Hiroki J., Mukai Y., Morikawa K., Ichiki T., Takahashi S., and Takeshita A. Long-term inhibition of rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Cir. Res. 93 (2003) 767-775
28. Amerongen G.P.v.N., Delft S.v., Vermeer M.A., Collard J.G., and van Hinsbergh V.W.M. Activation of RhoA by thrombin in endothelial hyperpermeability: role of rho kinase and protein tyrosine kinases. Cir. Res. 87 (2000) 335-340
29. Tangkijvanich P., Tam S.P., and Yee Jr. H.F. Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton. Hepatology 33 (2001) 74-80